Resmed (RMD) FY2025 results: revenue $5.1 billion, up 9.8% on the year
Resmed Inc. (RMD) reported revenue of $5.1 billion for fiscal 2025, the year ended 30 June 2025, up 9.8% on the year before. Net income was $1.4 billion, up 37.2%, and diluted earnings per share $9.51. The figures are the company's own, from the 10-K it filed with the SEC on 8 August 2025.
Revenue
$5.1 billion
+9.8% on the year
FY2018FY2025
Operating margin
32.7%
28.2% a year earlier
FY2018FY2025
Net income
$1.4 billion
+37.2% on the year
FY2018FY2025
Diluted EPS
$9.51
+37.4% on the year
FY2018FY2025
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Operating cash flow
1,752
1,401
693
+25.0%
Capital expenditure
89.9
99.5
120
-9.6%
Free cash flow
1,662
1,302
574
+27.6%
Free cash flow margin
32.3%
27.8%
13.6%
Cash from investing
-200
-270
-1,160
Cash from financing
-606
-1,119
423
Depreciation and amortisation
198
177
165
+12.2%
Share-based compensation
91.7
80.2
71.1
+14.3%
Buybacks
300
150
0.0
+100.0%
Dividends paid
311
282
258
+10.1%
Dividend per share
$2.12
$1.92
$1.76
+10.4%
Diluted shares, weighted
147m
148m
147m
-0.1%
Shares outstanding at period end
146m
147m
147m
-0.4%
Balance sheet
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Shareholders' equity
5,968
4,864
4,130
+22.7%
Debt
668
707
1,441
-5.5%
Operating lease liabilities
153
141
117
+8.2%
Other liabilities
1,385
1,160
1,064
+19.4%
Total liabilities and equity
8,174
6,872
6,752
+18.9%
Fixed assets
551
548
538
+0.5%
Goodwill
3,047
2,842
2,770
+7.2%
Intangible assets
465
486
552
-4.3%
Cash and equivalents
1,209
238
228
+407.4%
Receivables
939
837
705
+12.2%
Inventory
928
822
998
+12.8%
Other assets
1,035
1,099
960
-5.7%
Total assets
8,174
6,872
6,752
+18.9%
10-K for the year ended 30 June 2025, filed 8 August 2025: the filing.